DRIVE General Assembly

DRIVE Month 22 General Assembly takes place at Utrecht University

DRIVE held it's month 22 General Assembly meeting from March 23-24th 2017 at one of the oldest Universities in Europe, Utrecht University, Netherlands. The main focus of the meeting was planning the preclinical studies to test DRIVE's "ß-System" diabetes reversing implants. Representatives of all 14 DRIVE partner organisations were in attendance at the meeting, which was organised by Karina Scheiner, a DRIVE PhD student from host partner Utrecht University, with assistance from RCSI's DRIVE Programme Manager Dr Liam Burke.

The meeting was split over two days. The first day’s meeting was held in the new Department of Pharmaceutical Sciences building, within the University Campus located in the Science Park to the east of the city. Discussion focussed on the future translation to market of DRIVE’s technologies as well as the dissemination and outreach goals of the project. On the second day, the meeting moved to the University Hall in the city centre, where the main scientific work to be done in preparation for preclinical studies was discussed.

     This project has received funding from the EU Horizon 2020 research and innovation programme. Grant agreement No 645991